Apart from those particular features, COVID-19 and non-COVID-19 ARDS share the well-known involvement of both IL-8 and IL-1β within the airway, potentially driven by the release of endogenous mediators originating from injured alveolar cells (e.g., mitochondrial alarmins). This evidence concerns the gene CXCL8 and COVID-19.